A comprehensive study on long-term injury to nigral dopaminergic neurons following intracerebroventricular injection of lipopolysaccharide in rats

Journal of Neurochemistry

Volumn 123, Issue 5, 2012, Pages 771-780

  Zhou, Yan ^a   Zhang, Yanxin ^a   Li, Junquan ^a   Lv, Fengyue ^a   Zhao, Yongmei ^a   Duan, Deyi ^a   Xu, Qunyuan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

cholinergic neurons; dopaminergic neurons; inflammation; lipopolysaccharide; Parkinson's disease; serotonergic neurons

Indexed keywords

ALPHA SYNUCLEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; LIPOPOLYSACCHARIDE; PHOSPHO ALPHA SYNUCLEIN; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL LOSS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOWN REGULATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NERVE CELL LESION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SUBSTANTIA NIGRA; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INJECTIONS, INTRAVENTRICULAR; LIPOPOLYSACCHARIDES; MALE; MICROGLIA; MOTOR ACTIVITY; NERVE DEGENERATION; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA;

PARKINSONIA; RATTUS;

EID: 84868646008     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12010     Document Type: Article

References (33)

1. Abisambra J. F., Blair L. J., Hill S. E., et al,. (2010) Phosphorylation dynamics regulate Hsp27-mediated rescue of neuronal plasticity deficits in tau transgenic mice. J. Neurosci. 30, 15374-15382.
2. Anderson J. P., Walker D. E., Goldstein J. M., et al,. (2006) Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 281, 29739-29752.
3. Bower J. H., Maraganore D. M., Peterson B. J., McDonnell S. K., Ahlskog J. E., and, Rocca W. A., (2003) Head trauma preceding PD: a case-control study. Neurology 60, 1610-1615.
4. Dauer W., and, Przedborski S., (2003) Parkinson's disease: mechanisms and models. Neuron 39, 889-909.
5. Diedrich J., Wietgrefe S., Zupancic M., Staskus K., Retzel E., Haase A. T., and, Race R., (1987) The molecular pathogenesis of astrogliosis in scrapie and Alzheimer's disease. Microb. Pathog. 2, 435-442.
6. Hirsch E. C., (2000) Glial cells and Parkinson's disease. J. Neurol. 247 (Suppl 2), II58-II62.
7. Howells D. W., Porritt M. J., Wong J. Y., Batchelor P. E., Kalnins R., Hughes A. J., and, Donnan G. A., (2000) Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra. Exp. Neurol. 166, 127-135.
8. Hunter R. L., Dragicevic N., Seifert K., Choi D. Y., Liu M., Kim H. C., Cass W. A., Sullivan P. G., and, Bing G., (2007) Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system. J. Neurochem. 100, 1375-1386.
9. Hunter R. L., Cheng B., Choi D. Y., Liu M., Liu S., Cass W. A., and, Bing G., (2009) Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice. J. Neurosci. Res. 87, 1913-1921.
10. Irwin I., DeLanney L. E., McNeill T., Chan P., Forno L. S., Murphy G. M. Jr, Di Monte D. A., Sandy M. S., and, Langston J. W., (1994) Aging and the nigrostriatal dopamine system: a non-human primate study. Neurodegeneration 3, 251-265.
11. Ischiropoulos H., Zhu L., Chen J., Tsai M., Martin J. C., Smith C. D., and, Beckman J. S., (1992) Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys. 298, 431-437.
12. Kohutnicka M., Lewandowska E., Kurkowska-Jastrzebska I., Czlonkowski A., and, Czlonkowska A., (1998) Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP). Immunopharmacology 39, 167-180.
13. Kreutzberg G. W., (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318.
14. Li F. Q., Wang T., Pei Z., Liu B., and, Hong J. S., (2005) Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neurons. J. Neural Transm. 112, 331-347.
15. Ling Z., Zhu Y., Tong C., Snyder J. A., Lipton J. W., and, Carvey P. M., (2006) Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally. Exp. Neurol. 199, 499-512.
16. Liu B., Jiang J. W., Wilson B. C., Du L., Yang S. N., Wang J. Y., Wu G. C., Cao X. D., and, Hong J. S., (2000) Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide. J. Pharmacol. Exp. Ther. 295, 125-132.
17. Logroscino G., (2005) The role of early life environmental risk factors in Parkinson disease: what is the evidence? Environ. Health Perspect. 113, 1234-1238.
18. McCormack A. L., Di Monte D. A., Delfani K., Irwin I., DeLanney L. E., Langston W. J., and, Janson A. M., (2004) Aging of the nigrostriatal system in the squirrel monkey. J. Comp. Neurol. 471, 387-395.
19. McGeer P. L., Yasojima K., and, McGeer E. G., (2001) Inflammation in Parkinson's disease. Adv. Neurol. 86, 83-89.
20. Minghetti L., and, Levi G., (1998) Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog. Neurobiol. 54, 99-125.
21. Mogi M., Harada M., Kondo T., Riederer P., and, Nagatsu T., (1995) Brain beta 2-microglobulin levels are elevated in the striatum in Parkinson's disease. J. Neural Transm. Park. Dis. Dement. Sect. 9, 87-92.
22. Mouradian M. M., (2002) Recent advances in the genetics and pathogenesis of Parkinson disease. Neurology 58, 179-185.
23. Olanow C. W., and, Tatton W. G., (1999) Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci. 22, 123-144.
24. Page G., Rioux Bilan A., Ingrand S., Lafay-Chebassier C., Pain S., Perault Pochat M. C., Bouras C., Bayer T., and, Hugon J., (2006) Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease. Neuroscience 139, 1343-1354.
25. Pennathur S., Jackson-Lewis V., Przedborski S., and, Heinecke J. W., (1999) Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o, o'-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease. J. Biol. Chem. 274, 34621-34628.
26. Przedborski S., Jackson-Lewis V., Vila M., Wu D. C., Teismann P., Tieu K., Choi D. K., and, Cohen O., (2003) Free radical and nitric oxide toxicity in Parkinson's disease. Adv. Neurol. 91, 83-94.
27. Sanchez H. L., Silva L. B., Portiansky E. L., Herenu C. B., Goya R. G., and, Zuccolilli G. O., (2008) Dopaminergic mesencephalic systems and behavioral performance in very old rats. Neuroscience 154, 1598-1606.
28. Schmued L. C., and, Hopkins K. J., (2000) Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874, 123-130.
29. Stewart V. C., Sharpe M. A., Clark J. B., and, Heales S. J., (2000) Astrocyte-derived nitric oxide causes both reversible and irreversible damage to the neuronal mitochondrial respiratory chain. J. Neurochem. 75, 694-700.
30. Streit W. J., (2000) Microglial response to brain injury: a brief synopsis. Toxicol. Pathol. 28, 28-30.
31. Tacconi M. T., (1998) Neuronal death: is there a role for astrocytes? Neurochem. Res. 23, 759-765.
32. Tiveron M. C., Barboni E., Pliego Rivero F. B., Gormley A. M., Seeley P. J., Grosveld F., and, Morris R., (1992) Selective inhibition of neurite outgrowth on mature astrocytes by Thy-1 glycoprotein. Nature 355, 745-748.
33. Zhou H. F., Liu X. Y., Niu D. B., Li F. Q., He Q. H., and, Wang X. M., (2005) Triptolide protects dopaminergic neurons from inflammation-mediated damage induced by lipopolysaccharide intranigral injection. Neurobiol. Dis. 18, 441-449.